Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efgartigimod in IVIG Dependent Myasthenia Gravis Patients

NCT06765161 is registered in ClinicalTrials.gov with Clinique Neuro-Outaouais as lead sponsor.

NCT NCT06765161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06765161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efgartigimod in IVIG Dependent Myasthenia Gravis Patients
Lead sponsor
Clinique Neuro-Outaouais
Phase
Phase 3
Overall status
Recruiting
Start date
February 6, 2025
Completion date
January 6, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myasthaenia gravis